PHARMICELL

The current price of 005690 is 5750 KRW — it has decreased by 0.69% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange PHARMICELL stocks are traded under the ticker 005690.

005690 stock is 2.44% volatile and has beta coefficient of 1.06. Check out the list of the most volatile stocks — is PHARMICELL there?

Yes, you can track PHARMICELL financials in yearly and quarterly reports right on TradingView.

005690 stock has risen by 1.77% compared to the previous week, the month change is a 14.81% fall, over the last year PHARMICELL has showed a 36.11% decrease.

005690 net income for the last quarter is ‪1.23 B‬ KRW, while the quarter before that showed ‪1.07 B‬ KRW of net income which accounts for 15.19% change. Track more PHARMICELL financial stats to get the full picture.

No, 005690 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, 005690 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PHARMICELL stock right from TradingView charts — choose your broker and connect to your account.

005690 reached its all-time high on Apr 10, 2018 with the price of 26350 KRW, and its all-time low was 260 KRW and was reached on May 11, 2004.
See other stocks reaching their highest and lowest prices.

As of Apr 27, 2024, the company has 136.00 employees. See our rating of the largest employees — is PHARMICELL on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PHARMICELL technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PHARMICELL stock shows the sell signal. See more of PHARMICELL technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PHARMICELL EBITDA is ‪3.86 B‬ KRW, and current EBITDA margin is 6.74%. See more stats in PHARMICELL financial statements.